WASHINGTON, Nov. 10 -- Drug Enforcement Administration has issued a notice called: Adjustment to the 2026 Aggregate Production Quota for d, l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sale) Pursuant to 21 U.S.C. 826(h).
The notice was published in the Federal Register on Nov. 10 by Heather Achbach, Federal Register Liaison Officer, Drug Enforcement Administration.
Summary: The Drug Enforcement Administration (DEA) is adjusting the 2026 aggregate production quota for the schedule II controlled substances d, l-amphetamine, d-amphetamine (for sale), hydromorphone, and methylphenidate (for sale). In making this determination, DEA has considered the factors set forth in 21 CFR 1303.13(b) in accordance with 2...